Trial Outcomes & Findings for Adapting Body Reprogramming for Severe Asthma: a Feasibility Study (NCT NCT04980755)

Results Overview

Consistent course attendance with the course will be used to infer participants level of engagement with the course content. Reasons for consistent attendance, or poor attendance, will be explored further with participants during the semi-structured interviews.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

28 participants

Primary outcome timeframe

Week 4

Results posted on

2025-07-11

Participant Flow

Participant milestones

Participant milestones
Measure	Patients Enrolled in Body Reprogramming Patients enrolled in one of the Body Reprogramming courses
Body Reprogramming Courses STARTED	28
Body Reprogramming Courses COMPLETED	13
Body Reprogramming Courses NOT COMPLETED	15
Post-course Interviews STARTED	12
Post-course Interviews COMPLETED	12
Post-course Interviews NOT COMPLETED	0

Reasons for withdrawal

Reasons for withdrawal
Measure	Patients Enrolled in Body Reprogramming Patients enrolled in one of the Body Reprogramming courses
Body Reprogramming Courses Too unwell to attend	6
Body Reprogramming Courses Work commitment	2
Body Reprogramming Courses Unsure when the course started	1
Body Reprogramming Courses Could not be contacted to provide a reason	6

Baseline Characteristics

Adapting Body Reprogramming for Severe Asthma: a Feasibility Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Patients Enrolled in Body Reprogramming n=28 Participants Patients enrolled in one of the Body Reprogramming courses
Age, Continuous	50 Years n=5 Participants
Sex: Female, Male Female	25 Participants n=5 Participants
Sex: Female, Male Male	3 Participants n=5 Participants
Race/Ethnicity, Customized Caucasian	26 Participants n=5 Participants
Race/Ethnicity, Customized Mixed race	2 Participants n=5 Participants
Region of Enrollment United Kingdom	28 participants n=5 Participants

PRIMARY outcome

Timeframe: Week 4

Consistent course attendance with the course will be used to infer participants level of engagement with the course content. Reasons for consistent attendance, or poor attendance, will be explored further with participants during the semi-structured interviews.

Outcome measures

Outcome measures
Measure	Patients Enrolled in Body Reprogramming n=28 Participants Patients enrolled in one of the Body Reprogramming courses
Number of Participants Taking Part Who Completed All 4 Weeks of the Course	13 Participants

PRIMARY outcome

Timeframe: Baseline

By capturing this information, we will determine if one of our study questionnaires is routinely unfinished by the study participants. Reasons for this can be explored during the focus groups or one to one interviews.

Outcome measures

Outcome measures
Measure	Patients Enrolled in Body Reprogramming n=28 Participants Patients enrolled in one of the Body Reprogramming courses
Number and Percentage of Participants Who Complete the Study Questionnaires	16 Participants

PRIMARY outcome

Timeframe: 4 weeks

See outcome 2

Outcome measures

Outcome measures
Measure	Patients Enrolled in Body Reprogramming n=13 Participants Patients enrolled in one of the Body Reprogramming courses
Number and Percentage of Participants Who Complete the Study Questionnaires	8 Participants

SECONDARY outcome

Timeframe: 5 weeks

Outcome measures

Outcome measures
Measure	Patients Enrolled in Body Reprogramming n=28 Participants Patients enrolled in one of the Body Reprogramming courses
Number of Participants Who Attended Two or More Sessions and Were Invited to a Follow-up Interview	19 Participants

SECONDARY outcome

Timeframe: 5 weeks

Outcome measures

Outcome measures
Measure	Patients Enrolled in Body Reprogramming n=19 Participants Patients enrolled in one of the Body Reprogramming courses
Of Those Invited, the Number Who Accepted an Invitation to Take Part in a Follow-up Interview	12 Participants

Adverse Events

Patients Enrolled in Body Reprogramming

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Joseph Lanario

University of Plymouth

Phone: 01752 764403

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place